Activity of aflibercept (Afli) in combination with FOLFIRI (F) for patients with metastatic colorectal cancer (mCRC) in a real-life setting in Spain: Final results of the retrospective study Named Patient Program.

Javier Sastre, Isabela Díaz de Corcuera Frutos, José Miguel Martín Martìnez et al.|Journal of Clinical Oncology|2016

Cited by 0